Cargando…
COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802165/ https://www.ncbi.nlm.nih.gov/pubmed/35108600 http://dx.doi.org/10.1016/j.jinf.2022.01.033 |
| _version_ | 1784642619987460096 |
|---|---|
| author | Mattiuzzi, Camilla Lippi, Giuseppe |
| author_facet | Mattiuzzi, Camilla Lippi, Giuseppe |
| author_sort | Mattiuzzi, Camilla |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8802165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88021652022-01-31 COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections Mattiuzzi, Camilla Lippi, Giuseppe J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-05 2022-01-31 /pmc/articles/PMC8802165/ /pubmed/35108600 http://dx.doi.org/10.1016/j.jinf.2022.01.033 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Mattiuzzi, Camilla Lippi, Giuseppe COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title_full | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title_fullStr | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title_full_unstemmed | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title_short | COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections |
| title_sort | covid-19 vaccines efficacy in preventing or limiting sars-cov-2 infections |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802165/ https://www.ncbi.nlm.nih.gov/pubmed/35108600 http://dx.doi.org/10.1016/j.jinf.2022.01.033 |
| work_keys_str_mv | AT mattiuzzicamilla covid19vaccinesefficacyinpreventingorlimitingsarscov2infections AT lippigiuseppe covid19vaccinesefficacyinpreventingorlimitingsarscov2infections |